Xolair Enhances Oral Desensitization in Peanut Allergic Patients

Summary

This is a pilot feasibility study, using Xolair pretreatment for oral peanut desensitization.

Timeline

Start

2011-02

Primary completion

2013-09

Completion

2013-09

Publications

• Abdel-Gadir A, Schneider L, Casini A, Charbonnier LM, Little SV, Harrington T, Umetsu DT, Rachid R, Chatila TA. Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function. Clin Exp Allergy. 2018 Jul;48(7):825-836. doi: 10.1111/cea.13161. Epub 2018 May 29.

Drugs

Indications